Skip to main content
. 2018 Sep 27;2018:1065271. doi: 10.1155/2018/1065271

Table 2.

Characteristics of VA-therapy.

Patients, n
Total number of VA patients, n (%) 39 (100)

Preparations, n (%)
 Abnobaviscum 24 (61.5)
 Iscador 8 (20.5)
 Helixor 14 (35.9)
 Iscucin 4 (10.3)

Application, n (%)
 subcutaneous 33 (84.6)
 intravenous 18 (46.2)

Characteristics of VA-therapy applied additionally to standard of care (n = 39). Numbers in columns do not necessarily add to 39 as patients may have received various VA combinations of preparations and applications, respectively.